NURS 1566 Clinical Form 3: Clinical Medications Worksheets (You will need to make additional copies of these forms

) Generic Name Trade Name Montelukast Singulair Peak
3-4 hr

Pharmacologic: leukotriene antagonists

Dose 10 mg

Route Po

Time/frequency Q morning

within 24 hr

24 hr

Normal dosage range 10 mg once daily For IV meds, compatibility with IV drips and/or solutions N/A Nursing Implications (what to focus on) Contraindications/warnings/interactions
Contraindicated if there is a hypersensitivity. Use cautiously in Acute attacks of asthma, Hepatic impairment (may need lower doses), Reduction of corticosteroid therapy (may increase the risk of eosinophilic conditions). Drugs which induce the CYP450 enzyme system (phenobarbital and rifampin ) may decrease the effects of monteleukast

Why is your patient getting this medication for asthma Mechanism of action and indications (Why med ordered)
Action: Antagonizes the effects of leukotrienes, which mediate the following: Airway edema, Smooth muscle constriction Altered cellular activity; Result is decreased inflammatory process. Indicated for prevention and chronic treatment of asthma. Indicated for prevention and chronic treatment of asthma.

Common side effects
CNS: fatigue, headache, weakness, EENT: otitis (children), sinusitis (children), Resp: cough, rhinorrhea, GI: abdominal pain, diarrhea (children), dyspepsia, nausea (children), increased liver enzymes, Derm: rash, Misc: EOSINOPHILIC CONDITIONS (INCLUDING CHURG-STRAUSS SYNDROME), fever

Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically) none

Lab value alterations caused by medicine
May cause ↑ AST and ALT concentrations

Be sure to teach the patient the following about this medication
take medication daily in the evening, even if not experiencing symptoms of asthma. Do not double doses. Do not discontinue therapy without consulting health care professional. montelukast is not used to treat acute asthma attacks, but may be continued during an acute exacerbation. Patient should carry rapid-acting therapy for bronchospasm at all times. Advise patient to notify health care professional if more than the maximum number of short-acting bronchodilator treatments prescribed for a 24-hr period are needed

Nursing Process- Assessment (Pre-administration assessment) Lung sounds, respiratory function, and allergy symptoms.

Assessment Why would you hold or not give this med? In case of allergy

Evaluation Check after giving In case of allergy

Sign up to vote on this title
UsefulNot useful